Time course global gene expression analysis of an in vivo Candida biofilm.
暂无分享,去创建一个
D. Andes | J. Nett | K. Marchillo | A. Lepak | David R Andes | Jeniel E Nett | Alexander J Lepak | Karen Marchillo
[1] A. Mitchell,et al. Function of Candida albicans Adhesin Hwp1 in Biofilm Formation , 2006, Eukaryotic Cell.
[2] B. Wickes,et al. Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.
[3] R. Darouiche,et al. Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.
[4] D. Andes,et al. Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazole , 2006, Antimicrobial Agents and Chemotherapy.
[5] M. Coen,et al. Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-beta-glucosyltransferase. , 1997, Microbiology.
[6] Mahmoud A. Ghannoum,et al. Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.
[7] K. Ying,et al. cDNA Microarray Analysis of Differential Gene Expression in Candida albicans Biofilm Exposed to Farnesol , 2005, Antimicrobial Agents and Chemotherapy.
[8] Omar Antar,et al. Alcohol Dehydrogenase Restricts the Ability of the Pathogen Candida albicans To Form a Biofilm on Catheter Surfaces through an Ethanol-Based Mechanism , 2006, Infection and Immunity.
[9] Xiaomin Zhao,et al. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. , 2005, Microbiology.
[10] D. Andes,et al. Beta -1,3 glucan as a test for central venous catheter biofilm infection. , 2007, The Journal of infectious diseases.
[11] H. Tabuchi,et al. Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis , 1997, Journal of bacteriology.
[12] R. Donlan. Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] L. J. Douglas,et al. Biofilm formation by Candida species on the surface of catheter materials in vitro , 1994, Infection and immunity.
[14] K. Oh,et al. Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Regenberg,et al. Dip5p mediates high-affinity and high-capacity transport of L-glutamate and L-aspartate in Saccharomyces cerevisiae , 1998, Current Genetics.
[16] D. Andes,et al. Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model , 2004, Infection and Immunity.
[17] K. Nickerson,et al. Quorum Sensing in the Dimorphic FungusCandida albicans Is Mediated by Farnesol , 2001, Applied and Environmental Microbiology.
[18] A. Mitchell,et al. Complementary Adhesin Function in C. albicans Biofilm Formation , 2008, Current Biology.
[19] C. Mateus,et al. Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole , 2004, Antimicrobial Agents and Chemotherapy.
[20] Christophe d'Enfert,et al. Stage‐specific gene expression of Candida albicans in human blood , 2003, Molecular microbiology.
[21] L. J. Douglas,et al. Candida biofilms and their role in infection. , 2003, Trends in microbiology.
[22] S. Rupp,et al. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans , 2000, Molecular microbiology.
[23] M. Ghannoum,et al. Candida biofilms: antifungal resistance and emerging therapeutic options. , 2004, Current opinion in investigational drugs.
[24] C. Lan,et al. Genome-Wide Transcription Profiling of the Early Phase of Biofilm Formation by Candida albicans , 2005, Eukaryotic Cell.
[25] M. Raymond,et al. PDR16‐mediated azole resistance in Candida albicans , 2006, Molecular microbiology.
[26] Gordon Ramage,et al. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. , 2002, FEMS microbiology letters.
[27] G. Baillie,et al. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. , 2000, The Journal of antimicrobial chemotherapy.
[28] G. Baillie,et al. Production of extracellular matrix by Candida albicans biofilms. , 1998, Journal of medical microbiology.
[29] A. Mitchell,et al. Candida albicans Biofilm-Defective Mutants , 2005, Eukaryotic Cell.
[30] B. Regenberg,et al. Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae , 1999, Current Genetics.
[31] D. Andes,et al. Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance , 2006, Antimicrobial Agents and Chemotherapy.
[32] G. Fink,et al. Tyrosol is a quorum-sensing molecule in Candida albicans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Ghannoum,et al. Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols , 2003, Infection and Immunity.
[34] C. Kumamoto. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] Gerald R. Fink,et al. The glyoxylate cycle is required for fungal virulence , 2001, Nature.
[36] F. Rey,et al. Characterization of the CaENG1 Gene Encoding an Endo-1,3-β-Glucanase Involved in Cell Separation in Candida albicans , 2005, Current Microbiology.
[37] B. Wickes,et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. , 2002, The Journal of antimicrobial chemotherapy.
[38] Marcelo D. Vinces,et al. Alternative Candida albicans lifestyles: growth on surfaces. , 2005, Annual review of microbiology.
[39] A. Johnson,et al. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. , 1997, Science.
[40] D. Andes,et al. A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. , 2005, The Journal of infectious diseases.
[41] J. Lopez-Ribot,et al. Candida Biofilms: an Update , 2005, Eukaryotic Cell.
[42] D. Andes,et al. Candida albicans biofilm development, modeling a host-pathogen interaction. , 2006, Current opinion in microbiology.
[43] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[44] D. Andes,et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. , 2007, Antimicrobial agents and chemotherapy.
[45] M. Bard,et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. , 2004, The Journal of antimicrobial chemotherapy.
[46] N. Chauhan,et al. The Two-Component Signal Transduction Protein Chk1p Regulates Quorum Sensing in Candida albicans , 2004, Eukaryotic Cell.
[47] A. Mitchell,et al. Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo , 2006, PLoS pathogens.
[48] C. d’Enfert,et al. Candida albicans Biofilms: a Developmental State Associated With Specific and Stable Gene Expression Patterns , 2004, Eukaryotic Cell.
[49] A. Mitchell,et al. Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions , 2008, Cellular microbiology.
[50] R. Miller,et al. A Small Subpopulation of Blastospores in Candida albicans Biofilms Exhibit Resistance to Amphotericin B Associated with Differential Regulation of Ergosterol and β-1,6-Glucan Pathway Genes , 2006, Antimicrobial Agents and Chemotherapy.